{
    "2018-10-01": [
        [
            {
                "time": "2018-03-15",
                "original_text": "How GlaxoSmithKlineâ€™s Segments Performed",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "segments",
                        "performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Novo Nordisk: Health Canada Approves Tresiba For Children With Type 1 Diabetes",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Health Canada",
                        "Tresiba",
                        "Type 1 Diabetes",
                        "approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}